What is LOPJLB’s current signal on AMLX?

LOPJLB’s latest quantitative signal on Amylyx Pharmaceuticals, Inc. (AMLX) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is AMLX in?

Amylyx Pharmaceuticals, Inc. (AMLX) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Amylyx Pharmaceuticals, Inc. (AMLX) do?

Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under inve…

Where is Amylyx Pharmaceuticals, Inc. based / listed?

Amylyx Pharmaceuticals, Inc. is based in US, listed on NASDAQ.

Amylyx Pharmaceuticals, Inc. (AMLX)

Healthcare · Biotechnology · NASDAQ · US

$38.15-1.32%Close

BUYRECOVERY · day 53

[SCORES & PROFILE]

FUND: 19
VALUE: 8
GROWTH: 47
GARP: 6
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-31.8%

REV YoY-

ROE-52.9%

EPS YoY-

ROA-57.5%

GROSS

NET

[VALUATION]

P/E TTM-27.06

P/E FWD-

SECTOR PE22.66

INDUSTRY PE17.07

P/B17.74

P/FCF-

EV/EBITDA-28.03

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E2.20

ALTMAN Z-

CURR RATIO12.12

ND/EBITDA-

BETA-0.20

Amylyx Pharmaceuticals, Inc. (AMLX)

Key stats

Sector peers

Industry peers

Prediction markets

FUNDAMENTALS

Company news